Given that the introduction of anti-CD154 mAb may be associated with thromboembolic events, the presence of anti-CD154 autoantibodies in patients with SLE was associated with thrombocytopenia but not with thromboembolism [101]. Here, CD40LG is linked to systemic lupus erythematosus.